The hallmark of CML is the Philadelphia (Ph) chromosome which occurs as a result of a reciprocal chromosomal translocation between chromosomes 9 and 22, creating a new fusion gene, BCR-ABL, with constitutive tyrosine kinase activity [2]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.